Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of contrast-induced nephropathy after TAVI with sodium bicarbonate versus hypotonic saline
NL-OMON43053Phase 4Active, not recruiting
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in contrast-induced nephropathy (CIN) comparing Sodium bicarbonate with Hypotonic saline (2 arms). Primary endpoints: Development of contrast-induced nephropathy and Development of acute heart failure due to volume expansion. Started Oct 2016; status: active, not recruiting.
02
Drugs
sodium bicarbonatehypotonic saline
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NL-OMON43053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43053.